GlassScriptPhysician profile
Terry M Brown
NPI 1811085293
$2,117.03
in general payments reported to CMS, 2019-2025
8 companies · $522 in 2025
The $522 reported for 2025 was more than what a typical Sleep Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $337).
See the full distribution for Sleep Medicine (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.06 · 2020: $71.69 · 2021: $61.20 · 2022: $290 · 2023: $311 · 2024: $829 · 2025: $522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,186 · Education: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,186.43 |
| Education | $475.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $1,190.78 | 2020-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $632.47 | 2019-2025 | |
| Inspire Medical Systems, INC. | $122.02 | 2022 | |
| Axsome Therapeutics, INC. | $94.39 | 2023-2025 | Sunosi |
| Itamar Medical INC | $23.96 | 2022 | |
| Avadel Cns Pharmaceuticals, LLC | $22.98 | 2024 | Lumryz |
| Alkermes, INC. | $19.43 | 2019 | |
| Allergan, INC. | $11.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.